Portal:COVID-19/FeaturedPathways
From WikiPathways
| Line 58: | Line 58: | ||
* [[Pathway:WP4868]] | * [[Pathway:WP4868]] | ||
* [[Pathway:WP4927]] | * [[Pathway:WP4927]] | ||
| - | |||
* [[Pathway:WP4876]] | * [[Pathway:WP4876]] | ||
* [[Pathway:WP4883]] | * [[Pathway:WP4883]] | ||
* [[Pathway:WP4891]] | * [[Pathway:WP4891]] | ||
* [[Pathway:WP4884]] | * [[Pathway:WP4884]] | ||
| - | |||
* [[Pathway:WP4904]] | * [[Pathway:WP4904]] | ||
* [[Pathway:WP4936]] | * [[Pathway:WP4936]] | ||
| - | * [[Pathway: | + | * [[Pathway:WP4853]] |
| - | * [[Pathway: | + | * [[Pathway:WP4863]] |
| - | * [[Pathway: | + | * [[Pathway:WP4864]] |
| - | * [[Pathway: | + | * [[Pathway:WP4912]] |
| - | * [[Pathway: | + | * [[Pathway:WP4861]] |
| - | * [[Pathway: | + | * [[Pathway:WP4799]] |
| - | * [[Pathway: | + | * [[Pathway:WP4877]] |
| - | * [[Pathway: | + | * [[Pathway:WP4880]] |
| - | * [[Pathway: | + | |
| + | * [[Pathway:WP554]] | ||
| + | * [[Pathway:WP2729]] | ||
Revision as of 19:58, 9 September 2020
SARS-CoV-2 Pathways
|
Image does not exist SARS-CoV-2 and COVID-19 Pathway Collaborative project for curation of biological processes involved in the COVID-19 disease after SARS-Cov-2 infection. |
Image does not exist Hijack of Ubiquitination by SARS-CoV-2 SARS-CoV-2 includes a novel Orf10 that interacts with multiple members of the Cullin 2 ubiquitin ligase complex. |
Image does not exist Type I Interferon Induction and Signaling During SARS-CoV-2 Infection The induction and signaling of type I interferon with specific SARS-CoV-2 protein and relevant drug. |
Image does not exist COVID-19, thrombosis and anticoagulation |
|
Image does not exist Activation of NLRP3 Inflammasome by SARS-CoV-2 Orf3a from SARS-CoV has been shown to bind TRAF3 and activate the NLRP3 inflammasome. |
Image does not exist SARS-CoV-2 and Angiotensin-converting enzyme 2 (ACE2) receptor : Molecular mechanisms and potential therapeutic target |
Image does not exist COVID-19 AOP Experimental pathway to investigate overlap of virus-host interaction and adverse outcome pathways |
Image does not exist nsp9/nsp10-mediated SARS-CoV-2 pathogenesis Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis |
|
Image does not exist LDLRAD4 pathway in COVID-19 |
Image does not exist Overview of perturbations to host-cell autophagy, induced by distinct proteins of SARS-CoV-2 (Homo sapiens) |
Other coronaviruses: MERS, SARS-CoV, etc
|
Image does not exist Coronavirus lipid metabolism Lipid metabolism alternations that are related to infection by the corona virus. |
Image does not exist Host-pathogen interaction of human corona viruses - autophagy |
Image does not exist Host-pathogen interaction of human corona viruses - apoptosis |
Image does not exist SARS coronavirus and innate immunity |
|
Image does not exist ER stress response in Coronavirus infection |
Image does not exist Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV Spike protein |
Image does not exist Host-pathogen interaction of human corona viruses - MAPK signaling |
Image does not exist Host-pathogen interaction of human corona viruses - Interferon induction |
More about ACE2
|
Image does not exist ACE Inhibitor Pathway |
Image does not exist Metabolism of Angiotensinogen to Angiotensins (Reactome) |
List of featured pathways:
- Pathway:WP4846
- Pathway:WP4860
- Pathway:WP4868
- Pathway:WP4927
- Pathway:WP4876
- Pathway:WP4883
- Pathway:WP4891
- Pathway:WP4884
- Pathway:WP4904
- Pathway:WP4936
